RU2016107610A - Фармацевтическая композиция - Google Patents

Фармацевтическая композиция Download PDF

Info

Publication number
RU2016107610A
RU2016107610A RU2016107610A RU2016107610A RU2016107610A RU 2016107610 A RU2016107610 A RU 2016107610A RU 2016107610 A RU2016107610 A RU 2016107610A RU 2016107610 A RU2016107610 A RU 2016107610A RU 2016107610 A RU2016107610 A RU 2016107610A
Authority
RU
Russia
Prior art keywords
insulin
range
isoelectric point
derivative
metabolite
Prior art date
Application number
RU2016107610A
Other languages
English (en)
Russian (ru)
Inventor
Махарадж К. САХИБ
Джитендра Кашинат АМБУЛГЕ
Original Assignee
Вокхардт Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вокхардт Лимитед filed Critical Вокхардт Лимитед
Publication of RU2016107610A publication Critical patent/RU2016107610A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
RU2016107610A 2013-09-30 2014-09-29 Фармацевтическая композиция RU2016107610A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3124/MUM/2013 2013-09-30
IN3124MU2013 IN2013MU03124A (enExample) 2013-09-30 2014-09-29
PCT/IB2014/064922 WO2015044922A1 (en) 2013-09-30 2014-09-29 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
RU2016107610A true RU2016107610A (ru) 2017-11-03

Family

ID=51903957

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016107610A RU2016107610A (ru) 2013-09-30 2014-09-29 Фармацевтическая композиция

Country Status (10)

Country Link
US (1) US20160271226A1 (enExample)
EP (1) EP3052114A1 (enExample)
JP (1) JP2016531847A (enExample)
CN (1) CN105579052A (enExample)
AU (1) AU2014326181A1 (enExample)
BR (1) BR112016006963A2 (enExample)
IN (1) IN2013MU03124A (enExample)
RU (1) RU2016107610A (enExample)
SG (1) SG11201601477VA (enExample)
WO (1) WO2015044922A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108712910A (zh) * 2016-02-25 2018-10-26 沃克哈特有限公司 胰岛素和氨基酸的药物组合物
CN106729639B (zh) * 2017-01-10 2018-02-27 鲁南制药集团股份有限公司 一种甘精胰岛素注射液及其制备方法
PL4019039T3 (pl) 2017-07-27 2024-03-18 Adocia Kompozycje w postaci wodnego roztworu do wstrzykiwania zawierające co najmniej insulinę ludzką a21g i co najmniej jeden supresor glukagonu o działaniu posiłkowym
US20220280614A1 (en) * 2019-08-02 2022-09-08 Case Western Reserve University Premixed Ultra-Stable Single-Chain Insulin Analogue Formulations
EP3915572A1 (en) * 2020-05-29 2021-12-01 Adocia Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial action
EP3915571A1 (en) * 2020-05-29 2021-12-01 Adocia Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial action

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3316363A1 (de) 1983-05-05 1984-11-08 Deutsche Babcock Anlagen Ag, 4200 Oberhausen Walzenrost fuer muellverbrennungsanlagen
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DK257988D0 (da) 1988-05-11 1988-05-11 Novo Industri As Nye peptider
HUT56857A (en) 1988-12-23 1991-10-28 Novo Nordisk As Human insulin analogues
IL93282A (en) 1989-02-09 1995-08-31 Lilly Co Eli Insulin analogues
DK155690D0 (da) 1990-06-28 1990-06-28 Novo Nordisk As Nye peptider
AU2003218635A1 (en) * 2002-05-07 2003-11-11 Novo Nordisk A/S Soluble formulations comprising insulin aspart and insulin detemir
PL1883394T3 (pl) * 2005-05-23 2018-09-28 Sdg, Inc. Konstrukt lipidowy do dostarczania insuliny ssakowi
KR101389226B1 (ko) * 2005-05-23 2014-04-25 에스디지,인코포레이티드 포유동물에게 인슐린을 전달하기 위한 지질 구조물
US20070086952A1 (en) 2005-09-29 2007-04-19 Biodel, Inc. Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
US8084420B2 (en) 2005-09-29 2011-12-27 Biodel Inc. Rapid acting and long acting insulin combination formulations
US7713929B2 (en) * 2006-04-12 2010-05-11 Biodel Inc. Rapid acting and long acting insulin combination formulations
CN101454019A (zh) * 2006-04-12 2009-06-10 百达尔公司 速效和长效胰岛素联合制剂
WO2007121256A2 (en) 2006-04-12 2007-10-25 Biodel, Inc. Rapid acting and long acting insulin combination formulations
US8575096B2 (en) 2007-08-13 2013-11-05 Novo Nordisk A/S Rapid acting insulin analogues
CN101796071A (zh) 2007-08-13 2010-08-04 诺沃-诺迪斯克有限公司 快速作用的胰岛素类似物
US20120035103A1 (en) 2010-01-29 2012-02-09 Pillion Dennis J Method for administration of insulin and pharmaceutical composition thereof
WO2012080320A1 (en) * 2010-12-14 2012-06-21 Novo Nordisk A/S Fast-acting insulin in combination with long-acting insulin
WO2013021143A1 (fr) 2011-08-10 2013-02-14 Adocia Solution injectable d'au moins une insuline basale

Also Published As

Publication number Publication date
EP3052114A1 (en) 2016-08-10
SG11201601477VA (en) 2016-04-28
IN2013MU03124A (enExample) 2015-07-31
AU2014326181A1 (en) 2016-03-17
JP2016531847A (ja) 2016-10-13
CN105579052A (zh) 2016-05-11
US20160271226A1 (en) 2016-09-22
WO2015044922A1 (en) 2015-04-02
BR112016006963A2 (pt) 2017-08-01

Similar Documents

Publication Publication Date Title
ES2365410T3 (es) Formulaciones farmacéuticas que comprenden péptido de incretina y un disolvente polar aprótico.
RU2016119746A (ru) Стабильный состав инсулина глулизин
JP2018138578A5 (enExample)
RU2015137674A (ru) Стабилизированные фармацевтические составы аналогов инсулина и/или производные инсулина
JP2016539921A5 (enExample)
AR077455A1 (es) Preparaciones insulinicas de accion lenta
JP2011241213A5 (enExample)
PE20161408A1 (es) Composiciones de insulina de rapida accion
JP2017519018A5 (enExample)
EA028572B1 (ru) Стабильная композиция для парентеральной инъекции и способы ее получения и использования
JP2016532698A (ja) インスリン分泌性ペプチドの安定な水性非経口医薬組成物
MY158627A (en) Halogen-stabilized insulin
AR094180A1 (es) Derivados de exendina-4
MX369511B (es) Tratamiento de la diabetes mellitus mediante formulaciones de insulinas de acción prolongada.
PE20121170A1 (es) Composicion de insulina de accion prolongada
RU2012157683A (ru) Производные инсулина, содержащие дополнительные дисульфидные связи
JP2018528242A (ja) 非プロトン性極性溶媒中の安定な治療用グルカゴン製剤を製造するための方法
MY189079A (en) Insulin analogues with chlorinated amino acids
AR072441A1 (es) Procedimiento para la obtencion de un concentrado de factor von willebrand o del complejo de factor viii/factor von willebrand y utilizacion de los mismos
Ryou et al. Pyruvate-enriched cardioplegia suppresses cardiopulmonary bypass-induced myocardial inflammation
JP2020527784A (ja) 低血糖の治療に関する方法および医学的使用
JP2016531847A (ja) 医薬組成物
Miao et al. Dual pH/ROS-responsive carbon dot–based microneedles for biofilm disruption and diabetic wound regeneration
AR074820A1 (es) Composicion de microparticulas biocompatibles de acido alginico para la liberacion controlada de principios activos por via intravenosa
AR131148A1 (es) Composiciones de insulina de acción rápida (variantes de las mismas)